Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03264521
Other study ID # 1R21AT009124-01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 23, 2017
Est. completion date May 30, 2018

Study information

Verified date February 2021
Source RAND
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study aims to advance pain research by exploring feasibility of crowdsourcing patient pain data via Amazon Mechanical Turk, the largest and most studied crowdsourcing platform in the U.S. We will leverage an existing NIH/NCCIH grant as a comparison data (RAND Center of Excellence in Research on CAM; CERC) to conduct a feasibility study of new methods for gathering and analyzing data on chronic pain and engaging pain patients in health policy.


Description:

The study aims to advance the pain research by exploring the crowdsourcing approach for eliciting and analyzing the way in which individuals experience and understand chronic pain. Investigators will leverage an existing NIH/NCCIH grant (RAND Center of Excellence in Research on CAM; CERC) to conduct a feasibility study of new methods for gathering and analyzing data on chronic pain and engaging pain patients in health policy processes through three specific aims: Aim 1 (Inclusion): Gain access to chronic pain patients using crowdsourcing platform Amazon Mechanical Turk (MTurk). This aim explores whether crowdsourcing provides a credible method for patient inclusion. People with low back pain will be accessed via the crowdsourcing platform MTurk and asked to take health surveys that were also administered to a national clinical sample of chiropractic patients within a RAND study. Equivalency of validated, self-reported measures of low back pain obtained from crowdsourced versus "gold standard" data from the RAND study will be assessed. Similarities and differences between demographics and other pain and function variables between crowdsourced and RAND data will be analyzed. Subsamples of crowdsourced data will be analyzed to assess reliability of the extent to which data yields the same results across repeated crowdsourced samples. Aim 2 (Participation): Engage chronic pain patients in inclusion criteria setting for national pain treatment programs. This aim will intends to facilitate patient participation in NIH criteria-setting for program inclusion. Crowdsourced patients will assist with qualitative coding of data responses to the question, "What does chronic pain mean to you?" Investigators will explore whether crowdsourcing provides a valid method by which coding may be conducted, first measuring reliability across crowd samples, second testing the accuracy of participant coding as compared with expert coders at RAND Corporation. A method of assessing face validity will be tested as participants may create additional codes and give feedback by rating the importance of each dimension. Aim 3: Assess efficiency and quality of crowdsourced data as compared to CERC data. Investigators will draw quantitative comparisons of cost (labor/incentives), time, data quality (amount of text, missing data) across online crowdsourced and CERC study samples. The proposed study utilizes the resources of an existing NIH grant by exploring the feasibility of using innovative online methods for eliciting patient perspectives on chronic pain and for engaging patients in analyses procedures. The study provides an opportunity to determine whether patient chronic pain experiences and perspectives can be gathered through crowdsourcing using Amazon Mechanical Turk (MTurk), in a valid, replicable, and resource efficient way. Although focused on chronic low back pain, the study findings will have broad implications for patient engagement more generally. If the crowdsourcing methods produce data that is comparable to "gold standard" methods used in the RAND Study entitled, "Center of Excellence in Research on Chiropractic" (RAND/CERC Study), this new experimental system has the potential to provide low-cost and time-efficient methods to advance democratically-oriented research, evaluation, policy and ultimately patient-centered clinical care.


Recruitment information / eligibility

Status Completed
Enrollment 8193
Est. completion date May 30, 2018
Est. primary completion date December 22, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - At least 3 months of low back pain or self-reported chronic low back pain - Utilized chiropractic care for treating back pain Exclusion Criteria: - Under 21 years of age - No open legal or workers compensation case related to condition - No diagnosis from provider of medical condition, so must be non-specific low back pain.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Surveys
Web surveys about experiences with chronic low back pain, demographics, coding qualitative text.

Locations

Country Name City State
United States RAND Corporation Santa Monica California

Sponsors (2)

Lead Sponsor Collaborator
RAND Claremont Graduate University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary ODI Score Oswestry Disability Index: Validated low back pain function scale (0-100) day 1
Primary PROMIS-29 Patient-Reported Outcomes Measurement Information System, 29 items, Version 2: Validated, self-reported measure of global, physical, mental, and social health for adults in the general population and those living with a chronic condition. day 1
Primary Average Pain NRS (0-10) Numeric Rating Scale for pain intensity: Average pain in past seven days (0-10) day 1
Primary Worst Pain NRS (0-10) Numeric Rating Scale for pain intensity: worse pain in past seven days (0-10) day 1
Secondary Demographics Gender, Age, Race/Ethnicity, Education, Income, Employment Status, day 1
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3